# Atazanavir/Ritonavir and Zinc Pharmacokinetic Study

> **NCT01475227** · PHASE4 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 16 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** 1 Solvazinc tablet, day 2 to day 15
- **DRUG:** 1 Solvazinc tablet, day 15 to day 28

## Key facts

- **NCT ID:** NCT01475227
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475227, "Atazanavir/Ritonavir and Zinc Pharmacokinetic Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01475227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*